Could a sleep hormone ease diabetic nerve damage?

NCT ID NCT07036796

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study investigates whether adding melatonin to standard diabetes care can improve symptoms of diabetic peripheral neuropathy, a common complication causing pain and numbness in the feet and hands. The trial includes 60 adults aged 40-75 with type 2 diabetes and diagnosed nerve damage. Researchers will measure changes in markers of oxidative stress and inflammation, as well as symptom scores, over the treatment period.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
melatonin, a hormone supplement with antioxidant and anti-inflammatory properties
What this could lead to
If it works, this could point toward a simple, low-cost supplement to help manage diabetic nerve damage and reduce pain or numbness.
What could go wrong
This is a small, early-phase trial with only 60 participants, so results may not apply widely. Melatonin can cause drowsiness and may interact with other medications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ain Shams University hospital

    RECRUITING

    Cairo, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.